Skip to main content

Table 1 Patient characteristics

From: A randomized controlled trial evaluating the impact of selective axillary nerve block after arthroscopic subacromial decompression

 

Ropivacaine

Placebo

Gender, (female/male)

11/16

11/12

Age, yr.

53 (32–74)

53 (35–75)

Height, cm

173 (164–198)

171 (160–200)

Weight, kg

79 (51–108)

79 (53–130)

BMI, kg/m2

26 (21–35)

26 (21–33)

Dynamic pain, VAS (baseline)

68 (10–100)

67 (4–100)

  1. Values are medians and (range)